Global Anti-Neoplastic Pharmaceutical Agents Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Anti-Neoplastic Pharmaceutical Agents Market Overview

• 1.1 Product Overview and Scope of Anti-Neoplastic Pharmaceutical Agents
• 1.2 Classification of Anti-Neoplastic Pharmaceutical Agents by Types
  • 1.2.1 Global Anti-Neoplastic Pharmaceutical Agents Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Types in 2018
  • 1.2.3 Hormones and Antagonists
  • 1.2.4 Microorganism Products
  • 1.2.5 Plant Products
  • 1.2.6 Antitumor Antibiotics
  • 1.2.7 Alkylating Agents
  • 1.2.8 Antimetabolites
  • 1.2.9 Natural Products
• 1.3 Global Anti-Neoplastic Pharmaceutical Agents Market by Application
  • 1.3.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Lung Cancer
  • 1.3.3 Bladder Cancer
  • 1.3.4 Breast Cancer
  • 1.3.5 Cervical Cancer
  • 1.3.6 Leukemia
  • 1.3.7 Gynecological Cancer
  • 1.3.8 Other
• 1.4 Global Anti-Neoplastic Pharmaceutical Agents Market by Regions
  • 1.4.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Anti-Neoplastic Pharmaceutical Agents Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Anti-Neoplastic Pharmaceutical Agents Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anti-Neoplastic Pharmaceutical Agents Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Anti-Neoplastic Pharmaceutical Agents Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anti-Neoplastic Pharmaceutical Agents Status and Prospect (2014-2024)
• 1.5 Global Market Size of Anti-Neoplastic Pharmaceutical Agents (2014-2024)

2 Manufacturers Profiles

• 2.1 GlaxoSmithKline plc.
  • 2.1.1 Business Overview
  • 2.1.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 F. Hoffmann-La Roche Ltd
  • 2.2.1 Business Overview
  • 2.2.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Eli Lilly and Company
  • 2.3.1 Business Overview
  • 2.3.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Bristol-Myers Squibb Company
  • 2.4.1 Business Overview
  • 2.4.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Becton, Dickinson and Company
  • 2.5.1 Business Overview
  • 2.5.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Pfizer Inc.
  • 2.6.1 Business Overview
  • 2.6.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Novartis AG
  • 2.7.1 Business Overview
  • 2.7.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Novartis AG Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 AstraZeneca
  • 2.8.1 Business Overview
  • 2.8.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 AstraZeneca Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Gilead
  • 2.9.1 Business Overview
  • 2.9.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Gilead Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)

3 Global Anti-Neoplastic Pharmaceutical Agents Market Competition, by Players

• 3.1 Global Anti-Neoplastic Pharmaceutical Agents Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Anti-Neoplastic Pharmaceutical Agents Players Market Share
  • 3.2.2 Top 10 Anti-Neoplastic Pharmaceutical Agents Players Market Share
• 3.3 Market Competition Trend

4 Global Anti-Neoplastic Pharmaceutical Agents Market Size by Regions

• 4.1 Global Anti-Neoplastic Pharmaceutical Agents Revenue and Market Share by Regions
• 4.2 North America Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 4.3 Europe Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 4.5 South America Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)

5 North America Anti-Neoplastic Pharmaceutical Agents Revenue by Countries

• 5.1 North America Anti-Neoplastic Pharmaceutical Agents Revenue by Countries (2014-2019)
• 5.2 USA Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 5.3 Canada Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)

6 Europe Anti-Neoplastic Pharmaceutical Agents Revenue by Countries

• 6.1 Europe Anti-Neoplastic Pharmaceutical Agents Revenue by Countries (2014-2019)
• 6.2 Germany Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 6.3 UK Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 6.4 France Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 6.5 Russia Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 6.6 Italy Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Revenue by Countries

• 7.1 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Revenue by Countries (2014-2019)
• 7.2 China Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 7.3 Japan Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 7.4 Korea Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 7.5 India Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)

8 South America Anti-Neoplastic Pharmaceutical Agents Revenue by Countries

• 8.1 South America Anti-Neoplastic Pharmaceutical Agents Revenue by Countries (2014-2019)
• 8.2 Brazil Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Anti-Neoplastic Pharmaceutical Agents by Countries

• 9.1 Middle East and Africa Anti-Neoplastic Pharmaceutical Agents Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 9.3 UAE Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)

10 Global Anti-Neoplastic Pharmaceutical Agents Market Segment by Type

• 10.1 Global Anti-Neoplastic Pharmaceutical Agents Revenue and Market Share by Type (2014-2019)
• 10.2 Global Anti-Neoplastic Pharmaceutical Agents Market Forecast by Type (2019-2024)
• 10.3 Hormones and Antagonists Revenue Growth Rate (2014-2024)
• 10.4 Microorganism Products Revenue Growth Rate (2014-2024)
• 10.5 Plant Products Revenue Growth Rate (2014-2024)
• 10.6 Antitumor Antibiotics Revenue Growth Rate (2014-2024)
• 10.7 Alkylating Agents Revenue Growth Rate (2014-2024)
• 10.8 Antimetabolites Revenue Growth Rate (2014-2024)
• 10.9 Natural Products Revenue Growth Rate (2014-2024)

11 Global Anti-Neoplastic Pharmaceutical Agents Market Segment by Application

• 11.1 Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Application (2014-2019)
• 11.2 Anti-Neoplastic Pharmaceutical Agents Market Forecast by Application (2019-2024)
• 11.3 Lung Cancer Revenue Growth (2014-2019)
• 11.4 Bladder Cancer Revenue Growth (2014-2019)
• 11.5 Breast Cancer Revenue Growth (2014-2019)
• 11.6 Cervical Cancer Revenue Growth (2014-2019)
• 11.7 Leukemia Revenue Growth (2014-2019)
• 11.8 Gynecological Cancer Revenue Growth (2014-2019)
• 11.9 Other Revenue Growth (2014-2019)

12 Global Anti-Neoplastic Pharmaceutical Agents Market Size Forecast (2019-2024)

• 12.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size Forecast (2019-2024)
• 12.2 Global Anti-Neoplastic Pharmaceutical Agents Market Forecast by Regions (2019-2024)
• 12.3 North America Anti-Neoplastic Pharmaceutical Agents Revenue Market Forecast (2019-2024)
• 12.4 Europe Anti-Neoplastic Pharmaceutical Agents Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Revenue Market Forecast (2019-2024)
• 12.6 South America Anti-Neoplastic Pharmaceutical Agents Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Anti-Neoplastic Pharmaceutical Agents Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology